Same Indication

Insulin Glargine vs Yttrium Y 90 Ibritumomab Tiuxetan

Insulin Glargine vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview

This comparison examines the pharmacological differences between Insulin Glargine and Yttrium Y 90 Ibritumomab Tiuxetan.

Mechanism of Action

Insulin Glargine: Long-acting insulin analogue that binds insulin receptors.

Pharmacokinetics

Half-life: Insulin Glargine — 12-24 hours.

Chemical Properties

Type: Insulin Glargine — Protein; Yttrium Y 90 Ibritumomab Tiuxetan — Antibody.